News Releases

A team of Mayo Clinic Cancer Center scientists has been awarded a Specialized Program of Research Excellence (SPORE) grant in multiple myeloma from the National Cancer Institute. The Mayo Clinic Cancer Center is one of only three cancer centers to receive a SPORE grant for multiple myeloma cancer research.

By Kelley Luedke • August 31, 2015

On Tuesday, Aug. 18, DLMP staff and local Rochester leadership celebrated the grand opening of the Superior Drive Support Center expansion building. More than 1,000 employees and guests toured the new addition during the open house.

By Kelley Luedke • August 26, 2015

Diadexus, Inc., a diagnostics company developing and commercializing products that aid in the prediction of cardiac disease risk, and Mayo Clinic recently signed an agreement to collaborate in the areas of education, research, and innovation on the PLAC® Test for Lp‑PLA2 Activity. The test, which has been cleared by the FDA, is used to help identify risk for coronary heart disease in patients with no history of cardiovascular events.

By Kelley Luedke • July 27, 2015

Mayo Clinic reports that in the summer months, its physicians see an increase in patients being treated, and even hospitalized, for tick-borne illnesses. To protect you against tick-borne diseases, the Mayo Clinic Department of Laboratory Medicine and Pathology and its reference laboratory Mayo Medical Laboratories have developed “The ABCs of Ticks” flash cards.

By Kelley Luedke • July 1, 2015

University of Missouri Health Care has selected Mayo Medical Laboratories as its primary reference laboratory for advanced laboratory testing. The collaboration will make test results available to providers and patients faster through MU Health Care’s electronic medical record. It is also expected to save MU Health Care more than $1 million annually.

By Kelley Luedke • June 23, 2015

For the fourth year in a row, Mayo Laboratory Inquiry has been named a Center of Excellence by BenchmarkPortal, a global leader in the contact center industry.

By Kelley Luedke • May 6, 2015

Herceptin has been touted as a wonder drug for women with HER2-positive breast cancer, an aggressive form of the disease that is fueled by excess production of the HER2 protein. However, not all of these patients respond to the drug, and many who do respond eventually acquire resistance. A team of researchers led by Mayo Clinic has found a promising way to circumvent this obstacle.

By Kelley Luedke • April 28, 2015

Mayo Clinic’s launch of eight new next-generation sequencing (NGS) panels is intended to improve the lives of patients and families living with inherited cardiac conditions by aiding in the diagnosis and management of these complex disorders. These disorders include hypertrophic cardiomyopathy, dilated cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, Noonan syndrome, Marfan syndrome, long QT syndrome, and Brugada syndrome.

By Kelley Luedke • April 9, 2015

Delta Regional Medical Center (DRMC), based in Greenville, MS, has selected Mayo Medical Laboratories as its primary reference laboratory. With access to Mayo Medical Laboratories’ extensive menu of laboratory tests and clinical expertise, this partnership enables DRMC to offer advanced testing capabilities to better serve its communities.

By Kelley Luedke • April 8, 2015

Mayo Medical Laboratories and Mayo Clinic’s Laboratory Medicine and Pathology Graduate Medical Education Office have developed Mayo Clinic PathWays, an online learning tool for pathologists and for those who enjoy learning about medicine. Practical case studies will be posted weekly to the Mayo Medical Laboratories blog for medical professionals around the world.

By apriljosselyn • March 3, 2015

Mayo Medical Laboratories is partnering with Seattle Children’s Hospital to research and develop ways to help the children’s hospitals around the country decrease costs and potential errors associated with unnecessary laboratory testing.

By apriljosselyn • February 23, 2015

US Senator Amy Klobuchar will tour the Mayo Clinic Biobank and discuss the Precision Medicine Initiative with leadership from both the Mayo Clinic Center for Individualized Medicine and Mayo Medical Laboratories on Friday, Feb. 20 from 11:15 to 11:40 a.m.

By Kelley Luedke • February 19, 2015

GenomeDx Biosciences today announced the publication of a positive validation study for the Decipher® Prostate Cancer Classifier, a new genomic test that can direct appropriate use of radiation therapy following prostate surgery.

By Kelley Luedke • February 9, 2015